[ad_1]
Gen-test revolutionizes the diagnosis of cancer
A new test to diagnose cervical cancer is currently causing a sensation in the medical world. The new genetic test has detected more than 15,000 women, all with cervical cancer. It is therefore not only more effective, but also more favorable than all common tests, including cell smear (Pap test) and papillomavirus (HPV) test. The English research team is talking about a revolutionary result.
As part of a clinical screening study, researchers from the Queen Mary English University in London have tested the effectiveness of a new genetic test for cervical cancer diagnosis. Uterus in 15,744 women. The spectacular result: the test recognized the tumor disease in 100% of cases. Unlike other tests, the new method looks for chemical markers in DNA that uniquely identifies cancer. The research was recently published in the International Journal of Cancer.
Genetics, key to cancer isolation
"This is an extraordinary development," said the principal investigator, Professor Attila Lorincz, in a press release about the results of the study. Researchers were not only surprised at the quality of this cervical cancer test, but they also showed for the first time the key role of epigenetics in the diagnosis of cancer. "We are seeing more and more evidence that epigenetics can detect a range of early-stage cancers, including cervical cancer, bad cancer, pharyngeal cancer, colon cancer, and cancer." the prostate, "said the professor.
Better than the smear
The test predicted the progression of cervical cancer in participating women up to five years in advance. As reported by researchers, screening for cervical cancer is usually done by smear. However, this only recognizes cervical cancer in approximately 50% of cases. The recognition rate of the new genetic test is however 100%.
Better than the HPV test
Human papillomavirus (HPV) is considered a risk factor for the development of cervical cancer. To detect if a person is infected with HPV, an early HPV test is performed. According to the researchers, this test recognizes only the presence of viruses and not the risk of real cancer, which remains low despite the virus. This leads to unnecessary uncertainty for the majority of women infected with HPV.
Revolutionary projection
Professor Lorincz explains that the new genetic test reduces the number of screening appointments required. "It's really a huge step forward that will revolutionize the projection," said the expert. Millions of women and men infected with HPV will benefit. Even difficult to detect cancers such as adenocarcinoma could be clearly identified by the test.
When will the new test be available?
"The new test is a lot better than anything currently proposed, but it can take at least five years to put it in place," concludes Lorincz. The authors are certain that this test will prevail because it is cheaper and more effective than the Pap smear, which will allow effective early detection and considerable savings. (Vb)
Source link
